Phenomic AI Tackles Drug Discovery with AI-driven High-throughput Phenotypic Screens Using Antibody-based Assays
Phenomic AI conducts high-throughput phenotypic screens using artificial intelligence to analyze the resulting microscopy images. I sat down with three Phenomic AI biologists, Allison Nixon, Max London, and Elizabeth Koch, to learn more about the company and it’s technology.